全球经皮贴片市场规模、份额、趋势和成长分析报告（2026-2034年）

预计经皮贴片市场将从 2025 年的 93 亿美元成长到 2034 年的 150.2 亿美元，2026 年至 2034 年的复合年增长率为 5.47%。

随着医疗专业人员寻求便利且可控的给药方式，全球经皮贴剂市场正稳定成长。经经皮贴片透过皮肤将药物直接输送到血液中，从而实现稳定的给药效果并提高患者的遵守用药。这些贴片广泛用于疼痛管理、荷尔蒙疗法、戒烟及其他治疗。

多种因素共同推动了经皮贴片市场的扩张。慢性病盛行率的上升以及对非侵入性治疗方法需求的成长，都促进了经皮给药系统的应用。製药公司正加大研发投入，致力于开发能提高药物吸收率和疗效的新型贴片配方。

随着药物传输技术的不断进步，经皮贴片市场前景光明。材料和贴片设计的创新有望实现更多种类药物的传递。对便捷医疗保健解决方案和个人化治疗方法的日益增长的需求预计将推动该市场的持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球经皮贴片市场：按类型划分

• 市场分析、洞察与预测
• 单层含药黏合剂
• 多层含药黏合剂
• 矩阵
• 其他类型

第五章：全球经皮贴片市场：依应用领域划分

• 市场分析、洞察与预测
• 缓解疼痛
• 减少吸烟和戒烟支持
• 心血管疾病
• 神经系统疾病
• 荷尔蒙疗法
• 其他用途

第六章：全球经皮贴片市场：依通路划分

• 市场分析、洞察与预测
• 医院药房
• 零售药房
• 网路药房

第七章：全球经皮贴片市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • Teikoku Pharma USA Inc
  • Viatris Inc
  • Johnson & Johnson
  • Luye Pharma Group
  • Purdue Pharma Manufacturing LP
  • Henan Lingrui Pharmaceutical Co. Ltd
  • Samyang Biopharmaceuticals Corporation
  • Hisamitsu Pharmaceutical Co. Inc

The Transdermal Skin Patches Market size is expected to reach USD 15.02 Billion in 2034 from USD 9.30 Billion (2025) growing at a CAGR of 5.47% during 2026-2034.

The global transdermal skin patches market has grown steadily as healthcare providers seek convenient and controlled drug delivery methods. Transdermal patches deliver medication through the skin directly into the bloodstream, offering consistent dosing and improved patient compliance. These patches are widely used for pain management, hormone therapy, smoking cessation, and other medical treatments.

Several drivers are contributing to the expansion of the transdermal skin patches market. Increasing prevalence of chronic diseases and growing demand for non-invasive treatment options have encouraged the use of transdermal drug delivery systems. Pharmaceutical companies are investing in research to develop new patch formulations that improve drug absorption and therapeutic effectiveness.

Future prospects for the transdermal skin patches market appear promising as advancements in drug delivery technology continue. Innovations in materials and patch design may enable the delivery of a wider range of medications. Growing demand for convenient healthcare solutions and personalized treatment options is expected to support continued growth in this market.

MARKET SEGMENTATION

By Type

• Single-Layer Drug-In-Adhesive
• Multi-Layer Drug-In-Adhesive
• Matrix
• Other Types

By Application

• Pain Relief
• Smoking Reduction And Cessation Aid
• Cardiovascular Disorders
• Neurological Disorders
• Hormonal Therapy
• Other Applications

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Teva Pharmaceutical Industries Ltd, Novartis AG, Teikoku Pharma USA Inc, Viatris Inc, Johnson Johnson, Luye Pharma Group, Purdue Pharma Manufacturing LP, Henan Lingrui Pharmaceutical Co Ltd, Samyang Biopharmaceuticals Corporation, Hisamitsu Pharmaceutical Co Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Single-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Multi-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Matrix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Pain Relief Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Smoking Reduction And Cessation Aid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hormonal Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TRANSDERMAL SKIN PATCHES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Teva Pharmaceutical Industries Ltd
  • 9.2.2 Novartis AG
  • 9.2.3 Teikoku Pharma USA Inc
  • 9.2.4 Viatris Inc
  • 9.2.5 Johnson & Johnson
  • 9.2.6 Luye Pharma Group
  • 9.2.7 Purdue Pharma Manufacturing LP
  • 9.2.8 Henan Lingrui Pharmaceutical Co. Ltd
  • 9.2.9 Samyang Biopharmaceuticals Corporation
  • 9.2.10 Hisamitsu Pharmaceutical Co. Inc